TOKYO–(BUSINESS WIRE)–The Industry Leading Network of Intelligent Camera Ecosystem (NICE) Alliance today announces two new…
CHANDLER, Ariz.–(BUSINESS WIRE)–Everspin Technologies, Inc. (NASDAQ: MRAM), the market leader in MRAM, will release its…
POTOMAC, Md., Feb. 14, 2023 (GLOBE NEWSWIRE) — via InvestorWire — India Globalization Capital, Inc….
Partnership announced with Japanese giant Benefit One CAMBRIDGE, United Kingdom, Feb. 15, 2023 (GLOBE NEWSWIRE)…
FOX News Digital Sees Month Over Month Gains Across the Board FOX News Mobile App…
SYDNEY, AU, Feb 15, 2023 – (ACN Newswire) – Novotech, the leading Asia Pacific centred…
RALEIGH, N.C.–(BUSINESS WIRE)–Vontier Corporation (“Vontier”) (NYSE: VNT), a leading global provider of critical technologies and…
AUSTIN, Texas–(BUSINESS WIRE)–Stratus Properties Inc. (NASDAQ: STRS) (“Stratus” or the “Company”) today announced that it…
PEARL RIVER, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Nasdaq Hearings Panel…
Continues momentum with Presto Voice A.I. platform by adding Del Taco Restaurants as second drive-thru…
MONTREAL, Feb. 14, 2023 (GLOBE NEWSWIRE) — Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a…
Daix (France), Long Island City (New York, United States), February 14, 2023 – Inventiva (Euronext…
ROCKVILLE, Md., Feb. 14, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
MADRID, Spain, Feb. 14, 2023 (GLOBE NEWSWIRE) — The listed company Lleida.net (BME:LLN) (EPA:ALLLN) (OTCQX:LLEIF)…
GINDIE, QUEENSLAND, AUSTRALIA, Feb 15, 2023 – (ACN Newswire) – SwarmFarm Robotics today announced it…
Angela C. Drake elected Chief Financial Officer succeeding Peterson BLOOMINGTON, Minn.–(BUSINESS WIRE)–The Toro Company (NYSE:…
First known certified natural gas purchase for use in industrial manufacturing Certified natural gas considered…
RYE, N.Y.–(BUSINESS WIRE)–Acadia Realty Trust (NYSE: AKR) (“Acadia” or the “Company”) today reported operating results…
THE RESEARCH SHOWS THAT PP2A, THE TARGET OF LIXTE’S LEAD CLINICAL COMPOUND, LB-100, WHEN DEFICIENT,…
The AI-powered platform automates medication management to help prevent adverse drug reactions: the fourth leading…